LINC02142: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC02142

NCBI ID: G105374644

LINC02142

Other Name(s): long intergenic non-protein coding RNA 2142 | Long intergenic non-protein coding RNA 2142, transcript variant X2 | LINC02142 variant X2

LINC02142: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

LINC02142 is a long intergenic non-protein coding RNA (lncRNA) that has been identified in various studies as having potential to interact with various proteins and play a critical role in various cellular processes. Its unique structure and function have led to its potential as a drug target or biomarker. In this article, we will explore the properties of LINC02142 and its potential applications in drug discovery and diagnostics.

Properties of LINC02142

LINC02142 is a 21.1-kb RNA molecule that is predominantly expressed in the brain, heart, and kidneys. It is characterized by a unique structure that consists of a stem-loop region, a 5'-end cap, and a variable region. The stem-loop region is the most conserved part of the RNA molecule and is responsible for maintaining the overall structure of the molecule.

The 5'-end cap is a short RNA molecule that is added to the 3' end of the stem-loop region. It is composed of a single base, U, and has been shown to play a role in the stability and translation of the RNA molecule.

The variable region is the largest part of the LINC02142 molecule and is responsible for encoding the protein associated with the RNA. The protein encoded by LINC02142 has not yet been identified, but its structure and function are of interest because it is known to interact with various proteins.

Potential Applications

The unique properties of LINC02142 make it an attractive drug target or biomarker. Its conserved stem-loop region and 5'-end cap, combined with its variable region, suggest that it may be a good candidate for small molecules that can interact with the protein encoded by the RNA.

One potential application of LINC02142 as a drug target is its role in the regulation of cellular processes that are associated with various diseases, such as cancer, neurodegenerative diseases, and mental disorders. The regulation of these processes is often associated with the aberrant expression of genes, including LINC02142.

In addition to its potential as a drug target, LINC02142 may also be used as a biomarker for various diseases. Its expression and function have been observed in a variety of diseases, including cancer, neurodegenerative diseases, and mental disorders. These observations suggest that LINC02142 may be a useful biomarker for these diseases and could be used in diagnostic tests.

Conclusion

LINC02142 is a long intergenic non-protein coding RNA that has unique properties and functions. Its conserved stem-loop region, 5'-end cap, and variable region suggest that it may be a good candidate for small molecules that can interact with the protein encoded by the RNA. Its potential applications as a drug target or biomarker make it an attractive molecule for further study and potential clinical applications.

The discovery of LINC02142 has opened up new avenues for research into the regulation of cellular processes and the development of new therapeutic approaches for a variety of diseases. Further studies are needed to fully understand the properties and functions of this RNA and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2142

The "LINC02142 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02142 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets